STOCK TITAN

Align Technology, Inc. - ALGN STOCK NEWS

Welcome to our dedicated news page for Align Technology (Ticker: ALGN), a resource for investors and traders seeking the latest updates and insights on Align Technology.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Align Technology's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Align Technology's position in the market.

Rhea-AI Summary
Align Technology, Inc. (NASDAQ: ALGN) has been included in the Intellectual Property Owners Association annual report of the top 300 organizations granted U.S. patents. In 2023, Align is at position #270, with 158 U.S. patents granted, a 36% increase compared to 2022. The patents cover technologies that revolutionize the field of orthodontics and digital dentistry. The recognition reflects Align's investment in developing next-generation devices and technology that provide what their doctor customers want and need for their patients.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.27%
Tags
none
-
Rhea-AI Summary
Align Technology, Inc. (NASDAQ: ALGN) has announced the launch of the iTero Lumina™ intraoral scanner, powered by the new iTero Multi-Direct Capture™ technology. The scanner features a 3X wider field of capture in a 50% smaller and 45% lighter wand, delivering faster scanning speed, higher accuracy, superior visualization, and a more comfortable scanning experience. The iTero Lumina scanner is designed to capture more data, deliver exceptional scan quality, and remove the need for intraoral photos. It offers multi-angled scanning, a larger capture distance, and effortless scanning experience, setting a new standard in digital scanning technology. The launch aims to enhance clinical outcomes, increase practice efficiency, and deliver an elevated, more comfortable experience for clinicians and patients.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.27%
Tags
none
-
Rhea-AI Summary
Align Technology, Inc. reported Q4 and FY2023 total revenues up 6.1% and 3.4% year over year, respectively. Major milestones include 17 million Invisalign patients, 4 million Vivera retainers, and 100 thousand iTero scanner units sold in 2023. The company's 2023 total revenues were $3.9 billion, with clear aligner revenues of $3.2 billion and systems and services revenues of $662.9 million. The 2023 operating margin was 16.7%, with non-GAAP operating margin of 21.4%. The company repurchased $600 million of common stock in 2023. Q4'23 total revenues were $956.7 million, down 0.4% sequentially and up 6.1% year-over-year. Clear Aligner revenues were $781.9 million, down 1.6% sequentially and up 6.9% year-over-year. The company also unveiled the iTero Lumina intraoral scanner with significant improvements in scanning capabilities.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.27%
Tags
earnings
Rhea-AI Summary
Align Technology, Inc. (ALGN) completes the acquisition of Cubicure GmbH, a pioneer in direct 3D printing solutions, to strengthen its 3D printed product portfolio. The acquisition will support and scale Align’s strategic innovation roadmap and extend its printing, materials, and manufacturing capabilities.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.01%
Tags
acquisition
-
Rhea-AI Summary
Align Technology, Inc. (Nasdaq: ALGN) will report Q4 2023 financial results on January 31, 2024, after the market close. The financial results will be released at 4:00 p.m. ET and a conference call will follow at 4:30 p.m. ET. Tentative earnings release dates for fiscal 2024 have also been announced.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.85%
Tags
earnings
-
Rhea-AI Summary
Align Technology, a leading global medical device company (Nasdaq: ALGN), has announced that the U.S. Food and Drug Administration (FDA) has cleared Align’s Invisalign® Palatal Expander System for commercial availability in the U.S. The system is a modern and innovative direct 3D printed device based on proprietary and patented technology, providing a safe, comfortable, and clinically effective alternative to traditional palatal expanders. The Invisalign Palatal Expander System offers a full early intervention treatment solution for Phase 1 treatment, with broad patient applicability, including growing children, teens, and adults.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.62%
Tags
clinical trial
Rhea-AI Summary
Align Technology, Inc. (Nasdaq: ALGN) has announced that Health Canada updated the medical device license for its Invisalign® Palatal Expander System, a modern and innovative direct 3D printed device based on proprietary and patented technology. The updated license is for broad patient applicability, including growing children, teens, and adults. The Invisalign Palatal Expander is Align’s first direct 3D printed orthodontic device and provides a safe, comfortable, and clinically effective alternative to traditional palatal expanders.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.09%
Tags
none
-
Rhea-AI Summary
Align Technology, Inc. (NASDAQ: ALGN) appointed Mojdeh Poul, former EVP and Group President of 3M Health Care, and Kevin Conroy, President, CEO, and Chairman of the Board of Exact Sciences, to its Board of Directors. Both bring extensive experience in the healthcare industry, with Mojdeh specializing in business strategy and transformation, while Kevin has a track record for growth and innovative solutions. Mojdeh and Kevin will be included in the company’s slate of director nominees in the proxy statement for Align’s 2024 Annual Meeting of Shareholders.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.71%
Tags
management
-
Rhea-AI Summary
Align Technology, Inc. has opened its 2024 Annual Research Award Program, offering up to $300,000 in funding for dental research initiatives. The program aims to advance patient care in orthodontics and dentistry. Align Technology has funded approximately $3 million in research since 2010.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.13%
Tags
none
Rhea-AI Summary
Align Technology, Inc. plans to repurchase $100 million of its common stock through open market repurchases as part of its $1.0 billion stock repurchase program. The company's CEO, Joe Hogan, also intends to personally purchase $1.0 million of Align's common stock. The repurchases are expected to be completed by mid-December 2023 and will be funded with Align's cash on hand.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.17%
Tags
buyback
Align Technology, Inc.

Nasdaq:ALGN

ALGN Rankings

ALGN Stock Data

24.63B
69.95M
6.61%
88.22%
2.2%
Surgical Appliance and Supplies Manufacturing
Manufacturing
Link
US
San Jose

About ALGN

align technology is a global medical device company with industry-leading innovative products -- invisalign clear aligners and itero intraoral scanners -- that help dental professionals achieve the clinical results they expect and deliver effective, cutting-edge dental options to their patients. invisalign system invisalign clear aligners have been used to straighten teeth and treat minor to complex malocclusion for more than 3 million patients worldwide. the invisalign system is a combination of proprietary virtual modeling software and rapid mass-manufacturing processes used to develop a treatment plan and with custom-made aligners for each patient. invisalign is prescribed to patients through invisalign-trained orthodontists and general practitioner dentists (gp) and is offered in over 90 countries. learn more at www.invisalign.com itero intraoral scanner the itero scanner’s parallel confocal imaging technology uses optical and laser scanning to achieve a high level of precisi